Caplacizumab in the Treatment of Patients with Recurrent Thrombotic Thrombocytopenic Purpura (TTP)

Caplacizumab in the Treatment of Patients with Recurrent Thrombotic Thrombocytopenic Purpura (TTP)

We report two cases of recurrent thrombotic thrombocytopenic purpura, both patients without significant personal pathological antecedents, in which the evolution was favorable following the association of Caplacizumab with the classic treatment with plasmapheresis and cortisone therapy. We studied t...

Full description

Saved in:
Bibliographic Details
Main Authors: Mihaela-Sabrina HERDEA, Adela-Sara IONESCU, Oana PATRINOIU, Mihaela ANDREESCU
Format: Article
Language:English
Published: Romanian Society of Hematology 2025-03-01
Series:Documenta Haematologica
Subjects:
thrombotic thrombocytopenic purpura
caplacizumab
platelets
adamts 13
Online Access:https://www.dhrrh.ro/wp-content/uploads/2025/03/DHRRH-2025-1-art6.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items